Home
Conditions
Inclusion Body Myositis

Clinical trial condition

Inclusion Body Myositis

Explore clinical trials studying Inclusion Body Myositis. Study availability and eligibility vary by location and protocol.

26 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Inclusion Body Myositis trial results

Completed

A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

NCT04659031

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: Royal Adelaide Hospital Adelaide, South Australia, Australia

Royal Brisbane Herston, Australia

Perron Institute Perth, Australia

Royal North Shore Hospital Sydney, Australia

View Trial Details

Completed

Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis

NCT04421677

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +5 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

The Risk of Falls Index for Patients With Neuromuscular Disorders

NCT05890833

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations: Marko Mijic München, Bavaria, Germany

View Trial Details

Completed

Study of Arimoclomol in Inclusion Body Myositis (IBM)

NCT02753530

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: Phoenix Neurological Associates Phoenix, Arizona, United States

University of California, Irvine Irvine, California, United States

University of Colorado School of Medicine Aurora, Colorado, United States

University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Molecular Profile of the Evolution of Inclusion Body Myositis

NCT03299335

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: Hôpital Pasteur 2 - Service Système Nerveux Périphérique, Muscle et SLA Nice, France

View Trial Details

Completed

Study of Pioglitazone in Sporadic Inclusion Body Myositis

NCT03440034

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Disease, +5 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Establishing Muscle Impedance Parameters With Electrical Impedance Myography

NCT03633318

Conditions: IBM, Inclusion Body Myositis, Muscular Diseases, +5 more
Locations: Yale Physicians Building New Haven, Connecticut, United States

View Trial Details

Completed

Arimoclomol in Sporadic Inclusion Body Myositis

NCT00769860

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

University College London, MRC Centre for Neuromuscular Disease London, United Kingdom

View Trial Details

Completed

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

NCT00802815

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: Washington University Department of Neurology St Louis, Missouri, United States

View Trial Details

Completed

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

NCT00898989

Conditions: Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Diseases, +4 more
Locations: Hopital Pitié-Salpêtrière Paris, France

View Trial Details

Inclusion Body Myositis

Inclusion Body Myositis trial results

Related conditions